Alivus Life Sciences Ltd (ALIVUS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003513, "name": "Alivus Life", "stock_name": "Alivus Life", "full_name": "Alivus Life Sciences Ltd", "name_url": "stocks-analysis/alivus-life", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,091.40", "chg": 43.4, "chgp": "4.14%", "dir": 1, "prev_price": "1,048.00", "mcapval": "13,395.78 Cr", "mcap": "Small Cap", "scripcode": 543322, "symbol": "ALIVUS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE03Q201024", "curr_date": "May 26", "curr_time": "", "bse_nse_vol": "1.32 lacs", "exc_status": "Active", "traded_date": "May 26, 2026", "traded_date_str": "2026 05 26", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Alivus Life Sciences Ltd Surges 7.06% to Day's High of Rs 1123 — Outperforms Sector by 7.21 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-intraday-high-with-706-surge-on-26-may-2026-4013591", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_priceRelatedfactors_4013591.png", "date": "2026-05-26 10:32:06", "description": "The Sensex eked out a modest gain of 0.11% after a volatile session, but Alivus Life Sciences Ltd surged 7.06% on 26 Jun 2026, touching an intraday high of Rs 1123. This 7.21 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a broad market lift." }, { "title": "Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-4012764", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_4012764.png", "date": "2026-05-26 08:07:02", "description": "Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from Hold to Buy by MarketsMOJO, accompanied by a Mojo Score of 70.0, reflects growing investor confidence amid improving price action and technical parameters." }, { "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4010016", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_4010016.png", "date": "2026-05-25 08:03:23", "description": "Alivus Life Sciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a modest day decline of 1.87%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes. This analysis delves into the recent technical parameter changes, evaluating momentum oscillators, moving averages, and volume trends to provide a comprehensive view of the stock’s near-term outlook." }, { "title": "Alivus Life Sciences Ltd Valuation Shifts Signal Attractive Investment Opportunity", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-valuation-shifts-signal-attractive-investment-opportunity-4009900", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_valuationdot_4009900.png", "date": "2026-05-25 08:01:36", "description": "Alivus Life Sciences Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent dip in its share price. This change comes amid a challenging environment for the Pharmaceuticals & Biotechnology sector, where many peers remain expensive by comparison. Investors are now reassessing Alivus Life’s price-to-earnings and price-to-book ratios, which have become more compelling relative to historical averages and sector benchmarks." }, { "title": "Alivus Life Sciences Ltd Falls 0.85%: 4 Key Factors Driving the Weekly Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-falls-085-4-key-factors-driving-the-weekly-move-4008103", "imagepath": "", "date": "2026-05-23 12:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>18 May:</strong> Valuation metrics upgraded to attractive</p>\n <p><strong>20 May:</strong> Technical momentum upgrades to bullish outlook</p>\n <p><strong>21 May:</strong> Mojo Grade upgraded from Hold to Buy on improved fundamentals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,044.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,0..." }, { "title": "Alivus Life Sciences Ltd Upgraded to Buy on Improved Fundamentals and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-upgraded-to-buy-on-improved-fundamentals-and-technicals-4002331", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_mojoScore_4002331.png", "date": "2026-05-21 08:26:58", "description": "Alivus Life Sciences Ltd has seen its investment rating upgraded from Hold to Buy as of 20 May 2026, reflecting a nuanced shift in its financial performance, valuation metrics, technical indicators, and overall quality assessment. Despite a flat financial trend in the latest quarter, the company’s strong operational metrics and improved technical outlook have contributed to this positive reassessment." }, { "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4000251", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_4000251.png", "date": "2026-05-20 08:05:24", "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, suggesting a positive outlook for the pharmaceutical and biotechnology small-cap stock amid mixed market conditions." }, { "title": "Alivus Life Sciences Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3996728", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_mojoScore_3996728.png", "date": "2026-05-18 10:10:30", "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3996158", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlivusLifeScien_technicaldot_3996158.png", "date": "2026-05-18 08:03:09", "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market volatility." } ], "total": 298, "sid": "1003513", "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "21-May-2026", "details": "Please find enclosed herewith transcript of Earnings Call held on 15th May 2026 which is also made available on the website of the Company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "20-May-2026", "details": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "19-May-2026", "details": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25", "dt": "2025-09-01", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

18 May: Technical momentum shifts amid mixed indicator signals

18 May: Valuation metrics upgraded to attractive

20 May: Technical momentum upgrades to bullish outlook

21 May: Mojo Grade upgraded from Hold to Buy on improved fundamentals

Read full news article

Alivus Life Sciences Ltd Upgraded to Buy on Improved Fundamentals and Technicals

2026-05-21 08:26:58

Alivus Life Sciences Ltd has seen its investment rating upgraded from Hold to Buy as of 20 May 2026, reflecting a nuanced shift in its financial performance, valuation metrics, technical indicators, and overall quality assessment. Despite a flat financial trend in the latest quarter, the company’s strong operational metrics and improved technical outlook have contributed to this positive reassessment.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-20 08:05:24

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, suggesting a positive outlook for the pharmaceutical and biotechnology small-cap stock amid mixed market conditions.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-05-18 10:10:30

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-05-18 08:03:09

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market volatility.

Read full news article